Susquehanna International Group, LLP Avidity Biosciences, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$37.21 - $48.14 $3.72 Million - $4.82 Million	-100,100 Reduced 73.39%	36,300 $1.67 Million
Q2 2024 Aug 15, 2024	BUY	$22.73 - $40.85 $1.94 Million - $3.49 Million	85,500 Added 167.98%	136,400 $5.57 Million
Q1 2024 May 07, 2024	BUY	$9.16 - $25.52 $216,176 - $602,272	23,600 Added 86.45%	50,900 $1.3 Million
Q4 2023 Feb 14, 2024	BUY	$4.87 - $9.37 $132,951 - $255,800	27,300 New	27,300 $247,000
Q2 2023 Aug 11, 2023	BUY	$10.62 - $17.34 $230,453 - $376,278	21,700 New	21,700 $240,000
Q4 2022 Feb 14, 2023	BUY	$10.06 - $22.66 $682,068 - $1.54 Million	67,800 New	67,800 $1.5 Million

255

107M

224K

161K

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.2B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.